Xin Song

机构：West China Medical Center of Sichuan University · ORCID：0000-0002-0569-6452

发表论文 79 篇 · 总被引 1885 次 · h-index 19

代表论文

• Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma (2022 · Frontiers in Oncology · 被引 35)
• 3‐Mercaptopyruvate sulfurtransferase represses tumour progression and predicts prognosis in hepatocellular carcinoma (2022 · Liver International · 被引 18)
• Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study (2023 · International Journal of Surgery · 被引 15)
• hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration (2022 · Journal of Immunology Research · 被引 11)
• Deficiency in Epithelium RAD50 Aggravates UC via IL-6-Mediated JAK1/2-STAT3 Signaling and Promotes Development of Colitis-Associated Cancer in Mice (2024 · Journal of Crohn s and Colitis · 被引 10)
• Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China (2023 · Frontiers in Oncology · 被引 10)